https://arab.news/27z5f
RIYADH: Riyadh Gov. Prince Faisal bin Bandar received the newly appointed ambassador of Zimbabwe to the Kingdom, Jonathan Wutawunashe, in Riyadh on Monday.
During the meeting, Prince Faisal wished the ambassador success in his new duties. The two sides also discussed issues of common interest, the Saudi Press Agency reported.
Meanwhile, Hail Gov. Prince Abdulaziz bin Saad bin Abdulaziz held cordial talks with Ambassador of Sudan to the Kingdom Dafallah Al-Haj Ali Othman in Hail on Monday.
RIYADH: King Faisal Specialist Hospital and Research Center introduced a groundbreaking preventive treatment aimed at slowing the progression of type 1 diabetes, the Saudi Press Agency reported on Wednesday.
The new therapy is designed for adults and children aged eight years and older who are diagnosed at stage two of the disease. It marks the first time such a treatment has been implemented in the Kingdom.
The initial application involved two patients who met all the criteria outlined in the approved protocol. The step represents a major advance in early preventive care for one of the most common autoimmune conditions affecting children and adolescents.
Both cases were treated at the hospital’s Department of Pediatrics. For families already managing type 1 diabetes, the innovation brings new hope.
Siblings of affected children often face increased risk due to shared genetic and immune factors. Preventive options like this could significantly lower those risks in the future.
The treatment targets the early, pre-type 1 diabetes stage when insulin-producing pancreatic cells begin to deteriorate. Through early intervention, doctors can slow this damage, delay the onset of symptoms and help extend the time before full disease progression.
Implementing the therapy required careful preparation. The drug was compounded in the hospital pharmacy under a precise protocol, while nursing teams received training on administration, monitoring and managing possible reactions.
Medical staff were also briefed on patient selection and follow-up criteria based on the latest clinical guidelines.
According to the SPA, experts expect the program to inspire national research focused on the early stages of the disease and on developing preventive approaches that enhance quality of life for at-risk groups.
KFSH&RC continues to gain recognition on the global stage. It was ranked first in the Middle East and Africa, and 15th worldwide among the top 250 academic medical centers for 2025.
The hospital was also named the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance 2025.
Additionally, Newsweek included KFSH&RC on its lists of the World’s Best Hospitals (2025), the World’s Smartest Hospitals (2026) and the World’s Best Specialized Hospitals (2026).
